Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Institutional Review Board of The University of Texas Southwestern Medical Center (STU2020-1244) on 4 February 2021, with the most recent approval on 27 December 2022. The trial is registered with clinicaltrials.gov NCT#05019274.